{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:56:08Z","timestamp":1790920568415,"version":"4.1.0"},"reference-count":37,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3895,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidem. Drug Safe."],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1002\/pds.1113","type":"journal-article","created":{"date-parts":[[2005,5,12]],"date-time":"2005-05-12T13:46:41Z","timestamp":1115905601000},"page":"851-859","source":"Crossref","is-referenced-by-count":74,"title":["Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004"],"prefix":"10.1002","volume":"14","author":[{"given":"Theodore J.","family":"Cicero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Inciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar H.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Senay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.","family":"Woody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005]]},"reference":[{"key":"10.1002\/pds.1113-BIB1","first-page":"275","volume":"260","author":"Raffa","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/pds.1113-BIB2","first-page":"370","volume":"16","author":"Codd","year":"1990","journal-title":"Abst Soc Neurosci"},{"key":"10.1002\/pds.1113-BIB3","author":"Codd","year":"1991","unstructured":", , , . Opioid receptor affinity and inhibition of neurotransmitter uptake of tramadol and its enantiomers. The R. W. Johnson Pharmaceutical Research Institute Research Report. 1991; No. DD-90331, 1-22 [Accession No. 500,519]."},{"key":"10.1002\/pds.1113-BIB4","first-page":"88","volume":"6","author":"Lehmann","year":"1985","journal-title":"Schmerz Pain Douleur"},{"key":"10.1002\/pds.1113-BIB5","first-page":"234","volume":"191","author":"Husslein","year":"1987","journal-title":"Z Geburtshilfe Perinatol"},{"key":"10.1002\/pds.1113-BIB6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003495-199400471-00006","volume":"47","author":"Bud","year":"1994","journal-title":"Drugs"},{"key":"10.1002\/pds.1113-BIB7","author":"Villarreal","year":"1968","unstructured":". Evaluation of new compounds for morphine-like physician dependence in the rhesus monkey. Paper presented at a meeting of the National Academy of Sciences-National Research Council Committee on Problems of Drug Dependence, 30th Meeting. 1968; 1-15. (Bull. Prob. Drug Depend., Addendum 2, pp 1-15.)"},{"key":"10.1002\/pds.1113-BIB8","first-page":"122","volume":"28","author":"Frederichs","year":"1978","journal-title":"Arzneim Forsch Drug Res"},{"key":"10.1002\/pds.1113-BIB9","first-page":"125","volume":"28","author":"Murano","year":"1978","journal-title":"Arzneim Forsch (Drug Res)"},{"key":"10.1002\/pds.1113-BIB10","first-page":"158","volume":"28","author":"Yanagita","year":"1978","journal-title":"Arzneim Forsch (Drug Res)"},{"key":"10.1002\/pds.1113-BIB11","first-page":"199","volume":"28","author":"Arend","year":"1978","journal-title":"Arzneim Forsch"},{"key":"10.1002\/pds.1113-BIB12","first-page":"62","volume":"313","author":"Richter","year":"1980","journal-title":"Naunyn Schmeidebergs Arch Pharmacol"},{"key":"10.1002\/pds.1113-BIB13","first-page":"1742","volume":"35","author":"Richter","year":"1985","journal-title":"Arzneim Forsch"},{"key":"10.1002\/pds.1113-BIB14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0376-8716(91)90081-9","volume":"27","author":"Preston","year":"1991","journal-title":"Drug Alcohol Depend"},{"key":"10.1002\/pds.1113-BIB15","author":"Keup","year":"1993","unstructured":"Missbrauchsmuster bei abhangigkeit von alkohol, medikamenten und drogen: Fruhwarnsystem-daten f\u00fcr die bundesrepublik Duetschland 1976-1990 Lambertus, Freiburg im Breisgau. 1993."},{"key":"10.1002\/pds.1113-BIB16","author":"U. S. Food and Drug Administration","year":"2004","unstructured":"U. S. Food and Drug Administration. Strengthening the science base for regulatory decisions. Jane E. Henney, 10th Annual PDA\/FDA Joint Conference, Bethesda, Maryland. September 27, 1999; Available at: http:\/\/www.fda.gov\/oc\/speeches\/pdafdaconf.html [Accessed 3 March 2004]."},{"key":"10.1002\/pds.1113-BIB17","author":"U. S. Food and Drug Administration","year":"2004","unstructured":"U. S. Food and Drug Administration. Statement of Jane E. Henney, MD, before the subcommittee on oversight and investigations committee on commerce. October 3, 2000; Available at: http:\/\/www.fda.gov\/ola\/2000\/counterfeitdrugs.html. [Accessed 3 March 2004]."},{"key":"10.1002\/pds.1113-BIB18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0376-8716(99)00041-1","volume":"57","author":"Cicero","year":"1999","journal-title":"Drug Alcohol Depend"},{"key":"10.1002\/pds.1113-BIB19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0376-8716(02)00321-6","volume":"69","author":"Senay","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1002\/pds.1113-BIB20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0376-8716(03)00198-4","volume":"72","author":"Woody","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1002\/pds.1113-BIB21","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2105\/AJPH.91.9.1446","volume":"91","author":"Caulkins","year":"2001","journal-title":"Am J Public Health"},{"key":"10.1002\/pds.1113-BIB22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/sim.4780140522","volume":"14","author":"Hyatt","year":"1995","journal-title":"Stat Med"},{"key":"10.1002\/pds.1113-BIB23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0376-8716(00)00157-5","volume":"62","author":"Petry","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1002\/pds.1113-BIB24","doi-asserted-by":"crossref","first-page":"454","DOI":"10.15288\/jsa.1994.55.454","volume":"4","author":"Sloan","year":"1994","journal-title":"J Stud Alcohol"},{"key":"10.1002\/pds.1113-BIB25","author":"Substance Abuse and Mental Health Services Administration","year":"2003","unstructured":"Substance Abuse and Mental Health Services Administration, 2003. Results from the 2002 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NHSDA Series: H22, DHSS Publication No. SMA 03-3836, Rockville, MD."},{"key":"10.1002\/pds.1113-BIB26","author":"Substance Abuse and Mental Health Services Administration","year":"2003","unstructured":"Substance Abuse and Mental Health Services Administration. Emergency Department Trends from the Drug Abuse Warning Network, Final Estimates 1995-2002. Office of Applied Studies. 2003; NHSDA Series: D-24, DHSS Publication No. SMA 03-3780, Rockville, MD."},{"key":"10.1002\/pds.1113-BIB27","author":"Government Accounting Office (GAO)","year":"2003","unstructured":"Government Accounting Office (GAO). Report to Congressional Requesters. Prescription drugs: OxyContin abuse and diversion and efforts to address the problem. December 2003; GAO-04-0110."},{"key":"10.1002\/pds.1113-BIB28","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn). American Psychiatric Association: Washington, DC, 1994."},{"key":"10.1002\/pds.1113-BIB29","first-page":"123","volume":"302","author":"Porter","year":"1980","journal-title":"New Eng J Med"},{"key":"10.1002\/pds.1113-BIB30","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/jama.283.13.1710","volume":"283","author":"Joranson","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/pds.1113-BIB31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF02854840","volume":"17","author":"Passik","year":"2000","journal-title":"Adv Ther"},{"key":"10.1002\/pds.1113-BIB32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0885-3924(01)00410-9","volume":"23","author":"Joranson","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1002\/pds.1113-BIB33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0885-3924(95)00203-0","volume":"11","author":"Hill","year":"1996","journal-title":"J Pain Symptom Manage"},{"key":"10.1002\/pds.1113-BIB34","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/jama.283.13.1710","volume":"283","author":"Joranson","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.1002\/pds.1113-BIB35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0376-8716(03)00003-6","volume":"69","author":"Zacny","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1002\/pds.1113-BIB36","first-page":"22","author":"Inciardi","year":"2003","journal-title":"Consumer Research"},{"key":"10.1002\/pds.1113-BIB37","author":"National Institute on Drug Abuse, Community Epidemiology Work Group","year":"2002","unstructured":"National Institute on Drug Abuse, Community Epidemiology Work Group. Epidemiologic Trends in Drug Abuse Advance Report. National Institutes of Health, National Institute on Drug Abuse. DHHS, Bethesda, MD. December 2002."}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.1113","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pds.1113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T22:54:10Z","timestamp":1625352850000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.1113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.1113","relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}